Acutus Medical Reports Second Quarter 2022 Financial Results
August 11, 2022 16:05 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2022 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
Acutus Medical to Announce Second Quarter 2022 Financial Results
July 28, 2022 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed...
Acutus Medical Announces Approval of its AcQMap System and AcQMap 3D Imaging and Mapping Catheter in Japan
July 27, 2022 06:30 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed...
Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results
July 21, 2022 06:30 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 01, 2022 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., July 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
Acutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth Priorities
July 01, 2022 06:30 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., July 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross™ Line Extension Compatible with Watchman™ Delivery System
June 27, 2022 06:00 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed...
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 01, 2022 16:01 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
Acutus Medical completes enrollment in IDE trial with its AcQBlate® FORCE Sensing Ablation System
May 13, 2022 08:00 ET
|
Acutus Medical, Inc.
CARLSBAD, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today...